Be in the know. 17 key reads for Tuesday…

  1. Berkshire Hathaway to Buy $500 Million Stake in Brazil’s Nubank (Wall Street Journal)
  2. The Biggest Obstacle to a Boeing Reboot is Boeing (Bloomberg)
  3. Biogen Wins Landmark Alzheimer’s Drug Approval (Investor’s Business Daily)
  4. S. Retrieves Millions in Ransom Paid to Colonial Pipeline Hackers (Wall Street Journal)
  5. XPeng vs. Tesla: The Race for the Best EV Tech (Wall Street Journal)
  6. Corporate Taxes Will Rise One Way or Another (Wall Street Journal)
  7. Southwest orders 34 more of Boeing’s smallest 737 Max plane (CNBC)
  8. Emerging markets are about to break out, Oppenheimer analyst says (CNBC)
  9. Alibaba expands cloud products with livestream shopping in its battle with Amazon (CNBC)
  10. Clover Health’s Stock Price Surges After Becoming New Reddit Darling (Wall Street Journal)
  11. Since 2008, this has been the biggest signal for stock direction. Here’s where it’s telling investors to go now. (MarketWatch)
  12. Splunk stock gains on Summit upgrade after post-earnings pullback (SA)
  13. A Key Opioid Trial Begins Today. What Investors Need to Know. (Barron’s)
  14. Senate Could Pass Wide-Ranging China Bill. What to Know. (Barron’s)
  15. Cruise Prices Look Strong Amid Pent-Up Demand, Limited Supply, Flush Consumers (Barron’s)
  16. How a Cloud Is Lifting from Bluebird and Other Gene Therapy Stocks (Barron’s)
  17. Will Europe sign up to Joe Biden’s plan to counter China? (Financial Times)